UMeWorld Inc 10-Q for FY2026 Q3
UMeWorld Inc. (UMEW)
About this 10-Q
UMeWorld Inc filed this 10-Q on August 13, 2026, covering the quarter ended June 30, 2026 (FY2026 Q3).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $540.36K
- up 158363.0% from $341 a year earlier
- Net loss
- $92.89K
- compared with a net loss of $20.89K a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended
or
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from __________ to _______
Commission File Number:
(Exact name of registrant as specified in its charter) |
| ||
(State or other jurisdiction of incorporation or organization) |
| (IRS Employer Identification No.) |
| ||
(Address of principal executive offices) |
| (Zip Code) |
(
(Registrant’s telephone number, including area code)
N/A
(Former name, former address, and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
OTC Markets Group, Inc. (OTCID) |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
☒ | Smaller reporting company | ||
|
| Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Class | Outstanding at August 5, 2026 |
Common Stock, $0.0001 par value |
TABLE OF CONTENTS
| 2 |
| Table of Contents |
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
UMEWORLD INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
(Currency expressed in United States Dollars (“US$”), except for number of shares)
|
| As of |
| |||||
|
| June 30, 2026 (Unaudited) |
|
| September 30, 2025 (Audited) |
| ||
ASSETS |
|
|
|
|
|
| ||
CURRENT ASSETS |
|
|
|
|
|
| ||
Cash |
| $ |
|
| $ |
| ||
Deposit |
|
|
|
|
|
| ||
Prepayment |
|
|
|
|
|
| ||
Accounts Receivable |
|
|
|
|
|
| ||
Inventory |
|
|
|
|
|
| ||
TOTAL CURRENT ASSETS |
|
|
|
|
|
| ||
TOTAL ASSETS |
| $ |
|
| $ |
| ||
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT |
|
|
|
|
|
|
|
|
CURRENT LIABILITIES |
|
|
|
|
|
|
|
|
Accounts payable |
|
|
|
|
|
| ||
Due to related parties |
|
|
|
|
|
| ||
Accrued liabilities and other payables |
|
|
|
|
|
| ||
TOTAL CURRENT LIABILITIES |
|
|
|
|
|
| ||
TOTAL LIABILITIES |
| $ |
|
| $ |
| ||
|
|
|
|
|
|
|
|
|
STOCKHOLDERS’ DEFICIT |
|
|
|
|
|
|
|
|
Common shares: $ |
|
|
|
|
|
|
|
|
Authorized: |
|
|
|
|
|
| ||
Additional paid-in capital |
|
|
|
|
|
| ||
Accumulated other comprehensive income |
|
|
|
|
|
| ||
Accumulated deficit |
|
| ( | ) |
|
| ( | ) |
Total stockholders’ deficit |
|
| ( | ) |
|
| ( | ) |
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT |
| $ |
|
| $ |
| ||
The accompanying notes are an integral part of these consolidated financial statements.
| 3 |
| Table of Contents |
UMEWORLD INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(UNAUDITED)
(Currency expressed in United States Dollars (“US$”), except for number of shares)
|
| For the three months ended June 30, |
|
| For the nine months ended June 30, |
| ||||||||||
|
| 2026 |
|
| 2025 |
|
| 2026 |
|
| 2025 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
REVENUE |
| $ |
|
| $ |
|
| $ |
|
| $ |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenues |
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GROSS INCOME (LOSS) |
|
|
|
|
| ( | ) |
|
|
|
|
| ( | ) | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
| ||||
TOTAL OPERATING EXPENSES |
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LOSS FROM CONTINUING OPERATIONS |
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OTHER INCOME (EXPENSE) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income |
|
|
|
|
|
|
|
|
|
|
|
| ||||
TOTAL OTHER INCOME, NET |
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES |
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense |
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET LOSS |
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) |
Foreign currency translation (loss) income |
|
|
|
|
|
|
|
|
|
|
| - |
| |||
Total comprehensive loss |
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss from continuing operations per share of ordinary share - basic and diluted |
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) |
Weighted average number of common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted |
|
|
|
|
|
|
|
|
|
|
|
| ||||
The accompanying notes are an integral part of these consolidated financial statements.
| 4 |
| Table of Contents |
UMEWORLD INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT
(UNAUDITED)
(Currency expressed in United States Dollars (“US$”), except for number of shares)
|
| Common Stock |
|
| Additional paid-in |
|
| Accumulated |
|
| Accumulated other comprehensive income |
|
| Total stockholders’ |
| |||||||||
|
| Shares |
|
| Amount |
|
| capital |
|
| deficit |
|
| (loss) |
|
| deficit |
| ||||||
Balance as of September 30, 2024 |
|
|
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ | ( | ) | ||||
Net loss |
|
| - |
|
|
|
|
|
|
|
|
| ( | ) |
|
|
|
|
| ( | ) | |||
Balance as of December 31, 2024 |
|
|
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ | ( | ) | ||||
Net loss |
|
| - |
|
|
|
|
|
|
|
|
| ( | ) |
|
|
|
|
| ( | ) | |||
Balance as of March 31, 2025 |
|
|
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ | ( | ) | ||||
Net loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
| ( | ) |
|
|
|
|
|
| ( | ) |
Balance as of June 30, 2025 |
|
|
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ | ( | ) | ||||
|
| Common Stock |
|
| Additional paid-in |
|
| Accumulated |
|
| Accumulated other comprehensive income |
|
| Total stockholders’ |
| |||||||||
|
| Shares |
|
| Amount |
|
| capital |
|
| deficit |
|
| (loss) |
|
| deficit |
| ||||||
Balance as of September 30, 2025 |
|
|
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ | ( | ) | ||||
Net loss |
|
| - |
|
| $ |
|
|
|
|
| $ | ( | ) |
| $ |
|
| $ | ( | ) | |||
Foreign currency translation adjustment |
|
| - |
|
| $ |
|
| $ |
|
| $ |
|
| $ |
|
| $ |
| |||||
Balance as of December 31, 2025 |
|
|
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ | ( | ) | ||||
Stock issued for debt |
|
|
|
| $ |
|
| $ |
|
| $ |
|
| $ |
|
| $ |
| ||||||
Stock issued for cash |
|
|
|
| $ |
|
| $ |
|
| $ |
|
| $ |
|
| $ |
| ||||||
Net loss |
|
| - |
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ | ( | ) | |||
Foreign currency translation adjustment |
|
| - |
|
| $ |
|
| $ |
|
| $ |
|
| $ |
|
| $ |
| |||||
Balance as of March 31, 2026 |
|
|
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ | ( | ) | ||||
Net loss |
|
| - |
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ | ( | ) | |||
Foreign currency translation adjustment |
|
| - |
|
| $ |
|
| $ |
|
| $ |
|
| $ |
|
| $ |
| |||||
Balance as of June 30, 2026 |
|
|
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ | ( | ) | ||||
The accompanying notes are an integral part of these consolidated financial statements.
| 5 |
| Table of Contents |
UMEWORLD INC
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(Currency expressed in United States Dollars (“US$”), except for number of shares)
|
| For the three months ended June 30, |
|
| For the nine months ended June 30, |
| ||||||||||
|
| 2026 |
|
| 2025 |
|
| 2026 |
|
| 2025 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
CASH FLOWS FROM OPERATING ACTIVITIES |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Net loss |
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) |
Changes in assets and liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable |
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
Deposit |
|
|
|
|
|
|
|
| ( | ) |
|
|
| |||
Prepayment |
|
|
|
|
|
|
| ( | ) |
|
| ( | ) | |||
Inventory |
|
|
|
|
| ( | ) |
|
| ( | ) |
|
| ( | ) | |
Accounts payable |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Accrued liabilities and other payables |
|
|
|
|
| ( | ) |
|
|
|
|
| ( | ) | ||
Due to related parties |
|
|
|
|
|
|
|
| ) |
|
|
| ||||
NET CASH USED IN OPERATING ACTIVITIES |
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Proceeds from related parties |
|
|
|
|
| ( | ) |
|
|
|
|
|
| |||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET CASH PROVIDED BY FINANCING ACTIVITIES |
|
|
|
|
| ( | ) |
|
|
|
|
|
| |||
Effect of foreign exchange on cash |
|
|
|
|
|
|
|
|
|
|
|
| ||||
NET DECREASE IN CASH |
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
Cash and cash equivalents at beginning of year |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Cash and cash equivalents at end of year |
| $ | 86,259 |
|
| $ | 315 |
|
| $ |
|
| $ |
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid for interest |
| $ |
|
| $ |
|
| $ |
|
| $ |
| ||||
Cash paid for income taxes |
| $ |
|
| $ |
|
| $ |
|
| $ |
| ||||
Supplemental non-cash financing activity: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Related-party advances converted into common stock |
| $ |
|
| $ |
|
| $ |
|
| $ |
| ||||
The accompanying notes are an integral part of these consolidated financial statements.
| 6 |
| Table of Contents |
UMEWORLD INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
(Currency expressed in United States Dollars (“US$”), except for number of shares)
NOTE 1. NATURE OF BUSINESS AND GOING CONCERN
UMeWorld Inc. (the “Company”) is a holding company focused on functional nutrition and lipid-based consumer products and conducts its operations through wholly owned subsidiaries in the United States and the Asia-Pacific region.
The Company’s primary operating subsidiary, Dagola Inc., is engaged in the sales, distribution, and marketing of DAGola® branded diacylglycerol (“DAG”)-based cooking oil products in the United States through online marketplace platforms and direct-to-consumer channels.
During 2025, the Company established an Asia-Pacific holding structure through Dagola Hong Kong Limited and its wholly owned subsidiary, Guangzhou Duokanglong Special Medical Nutrition Technology Co., Ltd. In October 2025, Dagola Hong Kong Limited and its wholly owned PRC subsidiary became wholly owned subsidiaries of the Company through a reorganization involving entities under common control. The PRC subsidiary commenced revenue-generating activities in December 2025.
On October 2, 2025, the Company completed its redomiciliation from the British Virgin Islands to the State of Delaware and, in connection therewith, transitioned from a foreign private issuer to a U.S. domestic issuer for purposes of reporting under the Securities Exchange Act of 1934, as amended.
On January 16, 2026, the Company incorporated Verdant Sustainable Fuel Malaysia Sdn. Bhd. (“Verdant Malaysia”), a wholly owned subsidiary established to support the evaluation and development of sustainable aviation fuel (“SAF”) and related renewable fuels initiatives in Malaysia. Verdant Malaysia is currently engaged in preliminary project development and administrative activities.
The Company consolidates all entities in which it holds a controlling financial interest. All intercompany balances and transactions have been eliminated in consolidation. The Company does not utilize a variable interest entity structure.
As of June 30, 2026, the Company’s consolidated subsidiaries are as follows:
Name | Date of Incorporation | Place of Incorporation | Percentage of Interest | Principal Activities | Nature of Company |
Dagola Inc. | |||||
Dagola Hong Kong Limited | |||||
Guangzhou Duokanglong Special Medical Nutrition Technology Co., Ltd. | |||||
Verdant Sustainable Fuel Malaysia Sdn. Bhd. |
Going Concern
The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern and realize its assets and satisfy its liabilities in the normal course of business.
For the nine months ended June 30, 2026, the Company incurred a net loss of $
| 7 |
| Table of Contents |
Management’s plans to alleviate this substantial doubt include:
| · | pursuing additional business arrangements and growth opportunities in the functional nutrition and health-and-wellness markets through Dagola; |
|
|
|
| · | expanding distribution channels and product offerings to increase revenues; and |
|
|
|
| · | seeking additional capital through promissory notes, private placements, and other financing transactions. |
There can be no assurance that these plans will be successful or that additional financing will be available on acceptable terms, or at all. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of presentation
The accompanying interim unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
The interim unaudited condensed consolidated balance sheet as of June 30, 2026 and the related interim unaudited condensed consolidated statements of operations and cash flows for the three and nine months ended June 30, 2026 and 2025 have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations.
These interim unaudited condensed consolidated financial statements and related notes should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the fiscal year ended September 30, 2025 included in the Company’s Annual Report on Form 20-F, filed with the SEC on December 23, 2025. The Company completed its redomiciliation from the British Virgin Islands to the State of Delaware on October 2, 2025 and, in connection therewith, transitioned from a foreign private issuer to a U.S. domestic issuer.
In the opinion of management, all adjustments, consisting only of normal recurring adjustments, considered necessary for a fair presentation of the Company’s financial position as of June 30, 2026 and the results of operations and cash flows for the interim periods presented have been included. Interim results are not necessarily indicative of results for the full fiscal year or any future period.
Principles of consolidation
The accompanying unaudited condensed consolidated financial statements include the accounts of UMeWorld Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company consolidates all entities in which it holds a controlling financial interest, typically through ownership of a majority voting interest. Subsidiaries are included in the consolidated financial statements from the date control is obtained through the date control ceases.
In October 2025, Dagola Hong Kong Limited and its wholly owned subsidiary, Guangzhou Duokanglong Special Medical Nutrition Technology Co., Ltd., became wholly owned subsidiaries of the Company through a reorganization involving entities under common control. From that date forward, both entities have been included in the Company’s consolidated financial statements.
| 8 |
| Table of Contents |
On January 16, 2026, Verdant Sustainable Fuel Malaysia Sdn. Bhd. was incorporated in Malaysia. The entity was initially formed by the Company’s Chief Executive Officer and was subsequently transferred to the Company in a reorganization involving entities under common control, after which it became a wholly owned subsidiary of the Company.
The Company does not consolidate any entities under the variable interest entity model and does not utilize a variable interest entity structure.
Use of estimates
The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the balance sheet date, and the reported amounts of revenues and expenses during the periods presented.
Significant estimates reflected in the Company’s unaudited condensed consolidated financial statements include, but are not limited to, the allowance for expected credit losses on accounts receivable, inventory valuation and obsolescence reserves, impairment of long-lived assets, realizability of deferred tax assets, and other valuation allowances, where applicable. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.
Cash and cash equivalents
Cash and cash equivalents consist of cash on hand, demand deposits with financial institutions, and highly liquid investments with original maturities of three months or less at the time of purchase.
Revenue Recognition
The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers. Revenue is recognized when control of goods is transferred to customers in an amount that reflects the consideration the Company expects to receive in exchange for those goods.
The Company’s revenue consists primarily of sales of DAG-based cooking oil and related health and wellness products through online marketplace platforms and distributor channels in the United States and Asia-Pacific. Revenue is recognized at a point in time when control of the product transfers to the customer, which is generally upon shipment or delivery, depending on contractual terms and the nature of the sales channel.
The Company applies the five-step model under ASC 606 to its customer contracts: (i) identify the contract with the customer, (ii) identify the performance obligations, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when the performance obligation is satisfied. For product sales, the Company’s contracts generally contain a single performance obligation.
The transaction price is generally based on the fixed amount specified in the applicable sales agreement or purchase order. The Company does not provide material rebates, discounts, price concessions, promotional allowances, or rights of return. Accordingly, variable consideration was not material during the periods presented.
Payments received in advance of shipment are recorded as contract liabilities and recognized as revenue when control of the goods is transferred. Shipping and handling amounts charged to customers are included in revenue, and the related costs are included in cost of revenue.
| 9 |
| Table of Contents |
Accounts Receivable and Allowance for Expected Credit Losses
Accounts receivable are recorded at invoiced amounts and are non-interest bearing. The Company estimates expected credit losses based on historical collection experience, the aging of accounts receivable, customer-specific creditworthiness, current economic conditions, and reasonable and supportable forecasts.
The increase in accounts receivable as of June 30, 2026 primarily resulted from sales made during the period. As of August 8, 2026, approximately 36% of the accounts receivable outstanding as of June 30, 2026 had been subsequently collected, and the remaining balance continued to be within its contractual payment terms. Management also considered the contractual payment terms, aging of the remaining balance, customer payment history, and other available credit information. Based on this evaluation, management determined that no allowance for expected credit losses was required as of June 30, 2026.
Inventory
Inventory consists of finished goods and is stated at the lower of cost or net realizable value, with cost determined using the first-in, first-out (FIFO) method.
The Company records write-downs for excess, slow-moving, or obsolete inventory based on forecasted demand, product shelf life, and market conditions. Such write-downs are included in cost of revenue. No inventory write-offs were recorded during the nine months ended June 30, 2026. For the year ended September 30, 2025, the Company recorded inventory write-offs totaling $
Cost of Revenue
Cost of revenue consists primarily of product acquisition costs, contract manufacturing and bottling costs, packaging materials, freight and import charges, fulfillment fees, and platform distribution costs associated with product sales.
Foreign Currency Translation
The Company’s reporting currency is the U.S. dollar. The functional currencies of certain foreign subsidiaries are their respective local currencies. Assets and liabilities of these foreign subsidiaries are translated into U.S. dollars using exchange rates in effect at the balance sheet date. Revenues and expenses are translated using average exchange rates for the reporting period, and stockholders’ equity accounts are translated using historical exchange rates. Resulting foreign currency translation adjustments are recorded in accumulated other comprehensive income (loss).
| 10 |
| Table of Contents |
Related Party Transactions
The Company follows ASC Topic 850, Related Party, for the identification of related parties and the disclosure of related party transactions. Transactions with related parties are recorded at amounts agreed upon between the parties. Related party balances and transactions are disclosed separately in the accompanying notes to the unaudited condensed consolidated financial statements.
Income Taxes
The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. Current income taxes are provided based on taxable income for the period using enacted tax rates applicable in the jurisdictions in which the Company operates.
Deferred tax assets and liabilities are recognized using the asset and liability method for temporary differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the periods in which the temporary differences are expected to be realized or settled.
Deferred tax assets are recognized only to the extent that it is more likely than not that they will be realized. A valuation allowance is recorded when management determines that it is more likely than not that some or all of a deferred tax asset will not be realized.
The Company recognizes the benefit of an uncertain tax position only if it is more likely than not that the position will be sustained upon examination by the relevant taxing authority. The amount recognized is the largest amount of tax benefit that is greater than 50 percent likely to be realized upon settlement. Interest and penalties related to income taxes, if any, are recognized as a component of income tax expense. No material interest or penalties were recognized for the nine months ended June 30, 2026 and September 30, 2025.
The Company operates in multiple tax jurisdictions, including the United States and the People’s Republic of China, and is subject to examination by taxing authorities in those jurisdictions.
Comprehensive Loss
Comprehensive loss consists of two components: net loss and other comprehensive loss. Net loss includes all revenues, expenses, gains, and losses recognized in the condensed consolidated statements of operations.
Other comprehensive loss includes gains and losses that are recorded directly in stockholders’ equity and are excluded from net income under U.S. GAAP. For the Company, other comprehensive (loss consists primarily of foreign currency translation adjustments arising from the translation of the financial statements of subsidiaries whose functional currencies are not the U.S. dollar.
Earnings Loss Per Share
The Company computes earnings loss per share in accordance with ASC Topic 260, Earnings Per Share. Basic earnings loss per share is calculated by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period.
Diluted earnings per share reflects the potential dilution that could occur if securities or other contracts to issue common stock, such as options, warrants, or convertible instruments, were exercised or converted into common shares. Diluted earnings loss per share is computed using the weighted average number of common shares outstanding plus the effect of potentially dilutive common shares, when dilutive.
Potential common shares are excluded from the diluted earnings loss per share calculation when their effect would be anti-dilutive, including periods in which the Company reports a net loss.
For the nine months ended June 30, 2026 and 2025, diluted loss per share is the same as basic loss per share because the inclusion of potential common shares would have been anti-dilutive.
| 11 |
| Table of Contents |
Segment Reporting
The Company operates as a single operating and reportable segment. The Company’s Chief Executive Officer serves as the chief operating decision maker (“CODM”). The CODM regularly reviews the Company’s consolidated revenue, gross profit, operating expenses, and net loss to assess financial performance and make decisions regarding the allocation of resources. Because the Company’s operations constitute a single operating segment, the segment financial information is the same as the consolidated financial information presented in these unaudited condensed consolidated financial statements.
Commitments and Contingencies
The Company accounts for contingencies in accordance with ASC Topic 450-20, Contingencies. Certain conditions may exist as of the date the financial statements are issued that may result in a loss to the Company but will be resolved only when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves the exercise of judgment. In assessing loss contingencies related to legal proceedings pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of such proceedings or claims, as well as the perceived merits of the amount of relief sought or expected to be sought.
If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be reasonably estimated, the estimated liability is accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is reasonably possible, or is probable but cannot be reasonably estimated, the nature of the contingent liability and an estimate of the range of possible loss, if determinable and material, are disclosed.
Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees are disclosed.
From time to time, the Company may be involved in legal proceedings and claims arising in the ordinary course of business. As of June 30, 2026, the Company is not a party to any material legal proceedings, and management is not aware of any pending or threatened claims that are expected to have a material adverse effect on the Company’s consolidated financial position, results of operations, or cash flows. However, there can be no assurance that future developments will not materially adversely affect the Company’s business, financial position, results of operations, or cash flows.
Fair Value of Financial Instruments
The Company accounts for fair value measurements in accordance with ASC Topic 820, Fair Value Measurement, which defines fair value, establishes a three-level hierarchy for inputs used in measuring fair value, and requires related disclosures.
The fair value hierarchy prioritizes the inputs used in valuation techniques as follows:
| · | Level 1 — quoted prices (unadjusted) in active markets for identical assets or liabilities. |
| · | Level 2 — observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets or other inputs that are observable or can be corroborated by observable market data. |
| · | Level 3 — unobservable inputs that are supported by little or no market activity and are significant to the fair value measurement. |
Financial assets and liabilities are classified as Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques in which at least one significant assumption or input is unobservable.
If the inputs used to measure the fair value of financial assets and liabilities fall within different levels of the hierarchy, the classification is based on the lowest level input that is significant to the fair value measurement.
The carrying amounts of financial instruments included in current assets and current liabilities, including cash, accounts receivable, accounts payable, and accrued liabilities, approximate fair value due to their short-term maturities.
| 12 |
| Table of Contents |
Recently Issued Accounting Pronouncements
The Company has reviewed accounting standards issued by the Financial Accounting Standards Board (“FASB”) through the date of issuance of these condensed consolidated financial statements. The Company does not believe that any other recently issued, but not yet effective, accounting pronouncements will have a material impact on its condensed consolidated financial statements.
NOTE 3. INVENTORIES
Inventories consist of the following:
|
| As of |
| |||||
|
| June 30, 2026 |
|
| September 30, 2025 |
| ||
Finished goods |
| $ |
|
| $ |
| ||
|
| $ |
|
| $ |
| ||
As of June 30, 2026, the increase in finished goods inventory compared to September 30, 2025 primarily relates to initial product stocking associated with the expansion of sales activity in the Asia-Pacific region, following the establishment of the Company’s Hong Kong and PRC subsidiaries. Inventory levels related to United States operations remained generally consistent with prior periods.
No inventory write-offs were recorded during the nine months ended June 30, 2026. For the fiscal year ended September 30, 2025, the Company recorded inventory write-offs totaling $
NOTE 4. ACCOUNTS PAYABLE, ACCRUED LIABILITIES AND OTHER PAYABLES
Accounts payable, accrued liabilities and other payables consist of the following:
|
| As of |
| |||||
|
| June 30, 2026 |
|
| September 30, 2025 |
| ||
Accounts payable |
| $ |
|
| $ |
| ||
Accrued liabilities |
| $ |
|
| $ |
| ||
Advance from a non-related party |
| $ |
|
| $ |
| ||
Total |
| $ |
|
| $ |
| ||
Accounts payable primarily represents amounts due to suppliers for inventory purchases and other goods and services received in the ordinary course of business.
Accrued liabilities primarily consist of accrued professional fees and other operating expenses for which payment had not been made as of the balance sheet date.
The advance from a non-related party amounted to $
| 13 |
| Table of Contents |
NOTE 5. RELATED PARTY TRANSACTIONS AND BALANCES
The Company has relationships with certain directors, executive officers, and significant shareholders that are considered related parties under ASC Topic 850.
Name of Related Party | Relationship |
Michael Lee | Director and Chief Executive Officer of the Company |
Winfield, Yongbiao Ding | Chief Financial Officer of the Company |
Ford Moore | Director of the Company |
Dave Milroy | Director of the Company |
First Scion Investments Limited | Shareholder (>5% shareholding) |
On January 16, 2026, the Company acquired
On January 19, 2026, the Company approved the conversion of advances previously provided by the Chief Executive Officer and a director into shares of the Company’s common stock at a conversion price of $
The conversion reduced amounts due to related parties and increased stockholders’ equity.
Balances Due to Related Parties
Amounts due to related parties represent non-trade advances, unpaid compensation and expense reimbursements from directors and a significant shareholder arising in the ordinary course of supporting the Company’s operations. These balances are unsecured, non-interest bearing, and payable on demand.
Related Party |
| Balance as of June 30, 2026 |
|
| Balance as of September 30, 2025 |
| ||
Michael Lee (CEO & Director) |
| $ |
|
| $ |
| ||
Ford Moore (Director) |
| $ |
|
| $ |
| ||
First Scion Investments Limited (Shareholder) |
| $ |
|
| $ |
| ||
Total due to related parties |
| $ |
|
| $ |
| ||
Balances due to First Scion Investments Limited were carried forward from prior periods and remain unsecured, non-interest bearing, and payable on demand.
No other material related-party transactions occurred during the nine months ended June 30, 2026.
| 14 |
| Table of Contents |
NOTE 6. COMMITMENTS AND CONTINGENCIES
As of June 30, 2026 and September 30, 2025, the Company has no material lease obligations, capital commitments, or contingent liabilities that require accrual or material disclosure under ASC 450-20, Contingencies.
NOTE 7. STOCKHOLDERS’ EQUITY
Prior to October 2, 2025, the Company was incorporated in the British Virgin Islands as UMeWorld Limited, and its equity securities were designated as ordinary shares. As of September 30, 2025, UMeWorld Limited had
On October 2, 2025, the Company completed its redomiciliation from the British Virgin Islands to the State of Delaware. In connection with the redomiciliation, each issued and outstanding ordinary share of UMeWorld Limited was converted on a one-for-one basis into one share of common stock of UMeWorld Inc. The redomiciliation did not change the number of shares held by any stockholder.
Following the redomiciliation, the Company is authorized to issue up to
During the nine months ended June 30, 2026, the Company issued
No shares of common stock were issued during the three months ended June 30, 2026.
As of June 30, 2026, the Company had
NOTE 8. INCOME TAXES
Prior to October 2, 2025, the Company was incorporated in the British Virgin Islands and generally was not subject to income taxes. On October 2, 2025, the Company completed its redomiciliation to the United States (Delaware) and became subject to U.S. federal and applicable state income taxes. Dagola Inc. is subject to U.S. federal corporate income tax at a statutory rate of 21%, in addition to applicable state income taxes. Guangzhou Duokanglong Special Medical Nutrition Technology Co., Ltd. is subject to PRC enterprise income tax at a statutory rate of 25%. Verdant Sustainable Fuel Malaysia Sdn. Bhd. is subject to the applicable Malaysian corporate income tax regime; however, no material taxable activity had commenced as of June 30, 2026.
For the nine months ended June 30, 2026 and 2025, the Company recorded no provision for income taxes primarily due to operating losses, offsetting tax attributes, and the full valuation allowance recorded against deferred tax assets. The Company’s PRC subsidiary generated limited taxable income during the nine months ended June 30, 2026; however, the related income tax expense was not material to the consolidated financial statements. The reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:
|
| June 30, 2026 |
|
| June 30, 2025 |
| ||
U.S. federal statutory income tax rate |
|
| % |
|
| % | ||
Foreign tax rate differential |
|
| ( | )% |
|
|
| |
Change in valuation allowance |
|
| ( | )% |
|
| ( | )% |
Other permanent differences |
|
|
|
|
|
| ||
Effective income tax rate |
|
| % |
|
| % | ||
The Company recognizes interest and penalties related to uncertain tax positions, if any, as a component of income tax expense. As of June 30, 2026 and September 30, 2025, the Company had no accrued interest or penalties related to uncertain tax positions. The Company files income tax returns in the United States and applicable foreign jurisdictions. Tax years remain subject to examination by taxing authorities in accordance with the respective statutes of limitation.
| 15 |
| Table of Contents |
NOTE 9. SEGMENT REPORTING
The Company applies ASC Topic 280, Segment Reporting, in determining its reportable segments. An operating segment is a component of the business for which discrete financial information is available and regularly reviewed by the Company’s Chief Operating Decision Maker (“CODM”) in assessing performance and allocating resources.
Management has determined that the Company operates as one operating and reportable segment, as its operations are focused on the development, marketing, and sale of functional nutritional and DAG-based cooking oil products under the DAGola® brand. The Company’s Chief Executive Officer serves as the chief operating decision maker (“CODM”). The CODM primarily uses consolidated net loss to assess segment performance and allocate resources and also reviews consolidated revenue and gross profit. The segment’s accounting policies are the same as those described in Note 2, and the segment amounts reviewed by the CODM are the same as the corresponding consolidated amounts presented in the Company’s unaudited condensed consolidated financial statements.
For the nine months ended June 30, 2026, substantially all revenues were generated from distribution activities in the People’s Republic of China, with nominal revenues generated in the United States. For the nine months ended June 30, 2025, revenues were generated from sales in the United States only. The Company operates as a single reportable segment, and its segment revenues, expenses, assets, and net loss are therefore the same as the corresponding consolidated amounts presented in these unaudited condensed consolidated financial statements.
NOTE 10. CONCENTRATIONS OF RISK
The Company is exposed to various risks arising from its business operations. The primary risks include foreign currency risk, liquidity risk, product-liability exposure, and concentration risks related to customers and suppliers.
(a) Foreign Currency Exchange Rate Risk
The Company’s reporting currency is the U.S. dollar. Substantially all expenses were denominated in U.S. dollars during the nine months ended June 30, 2026 and 2025.
During the nine months ended June 30, 2026, the Company expanded its sales activities in Asia, and a portion of the Company’s revenue was generated from customers in the People’s Republic of China, resulting in transactions denominated in Renminbi (“RMB”). The Company is therefore exposed to foreign currency exchange rate risk associated with RMB-denominated transactions.
The Company also maintains subsidiaries in Hong Kong, the People’s Republic of China, and Malaysia. The Hong Kong subsidiary is a non-operating holding entity and does not have significant foreign currency-denominated transactions. The Malaysia subsidiary is currently engaged in preliminary project development and administrative activities related to sustainable aviation fuel initiatives and incurred limited expenses denominated in Malaysian Ringgit (“MYR”) during the period. The Company’s exposure to foreign currency exchange rate risk was not material as of June 30, 2026.
(b) Liquidity Risk
The Company has incurred recurring operating losses and has a working capital deficiency. The Company’s ability to meet its obligations depends on generating additional revenues and obtaining external financing. These conditions are described further in the Going Concern note to the condensed consolidated financial statements.
(c) Product Liability Exposure
The Company records accruals for product-related claims when losses are probable and reasonably estimable. Historically, product returns and claims have not been material. No product liability accruals were recorded as of June 30, 2026 and September 30, 2025.
| 16 |
| Table of Contents |
d) Customer / Revenue Concentration
The Company generates revenue through a limited number of distribution channels, including online marketplace platforms and distribution partners.
For the nine months ended June 30, 2026, two customers accounted for approximately
For the nine months ended June 30, 2025, substantially all of the Company’s revenue was generated through a single online marketplace channel.
Because the Company currently relies on a limited number of significant customers and sales channels, the loss of a significant customer or distribution channel, or a material reduction in sales to or through such customers or channels, could adversely affect the Company’s revenues, operating results, and cash flows.
(e) Geographic Concentration
The Company generates revenue in the People’s Republic of China and the United States. Revenue by geographic market is attributed based on the location of the customer.
For the nine months ended June 30, 2026, approximately
For the nine months ended June 30, 2025,
Changes in economic conditions, regulatory environments, trade policies, or market demand in these markets could adversely affect the Company’s revenues, operating results, and cash flows.
(f) Supplier Concentration
Any disruption in this supplier relationship could adversely affect the Company’s operations.
The Company relies on third-party suppliers and manufacturing partners for key product inputs and finished goods.
For the nine months ended June 30, 2026, one supplier, which serves as the Company’s primary manufacturing partner for DAG oil, accounted for approximately
For the nine months ended June 30, 2025, the Company relied on a single supplier for substantially all of its cost of revenues.
Due to the specialized nature of DAG oil production, transitioning to an alternative supplier could require technical validation, commercial qualification, and regulatory and quality review. Consequently, the loss of, or a disruption in the relationship with, a significant supplier could result in supply interruptions, increased product costs, or delays in fulfilling customer orders and could adversely affect the Company’s operations, financial condition, and results of operations.
NOTE 11. SUBSEQUENT EVENTS
In accordance with ASC Topic 855, “Subsequent Events,” the Company has evaluated events and transactions that occurred after June 30, 2026 through the date these condensed consolidated financial statements were issued.
The Company did not identify any subsequent events that require adjustment to or disclosure in the condensed consolidated financial statements.
| 17 |
| Table of Contents |
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The information contained in this Quarterly Report on Form 10-Q updates the information contained in the Company’s Annual Report on Form 20-F for the fiscal year ended September 30, 2025. This discussion should be read together with the audited consolidated financial statements and related notes included in that report, as well as the unaudited condensed consolidated financial statements and related notes included elsewhere in this Form 10-Q.
This Management’s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are typically identified by words such as “may,” “will,” “expect,” “anticipate,” “believe,” “estimate,” or similar expressions.
Forward-looking statements speak only as of the date of this Quarterly Report. The Company undertakes no obligation to update any forward-looking statements, except as required by law. Readers are cautioned not to place undue reliance on these forward-looking statements.
Company Overview
UMeWorld Inc. (the “Company”) is a holding company focused on functional nutrition and health and wellness products. Following its exit from the education business in 2021, the Company repositioned its operations toward diacylglycerol (“DAG”)-based cooking oil and related products marketed under the DAGola® brand through its wholly owned subsidiary, Dagola Inc., a Wyoming corporation.
The Company’s products are sold primarily through online marketplace platforms and direct-to-consumer channels in the United States. During the three months ended June 30, 2026, the Company continued to expand its sales and distribution activities in the Asia-Pacific region through its subsidiaries in Hong Kong and the People’s Republic of China.
Dagola Hong Kong Limited serves as a regional holding entity. Its wholly owned subsidiary, Guangzhou Duokanglong Special Medical Nutrition Technology Co., Ltd., supports regulatory compliance, distribution development, and early-stage commercialization activities in Mainland China.
On October 2, 2025, the Company completed its redomiciliation from the British Virgin Islands to the State of Delaware and, in connection therewith, transitioned from a foreign private issuer to a U.S. domestic issuer for purposes of reporting under the Securities Exchange Act of 1934, as amended.
The Company’s strategy is focused on expanding distribution channels, increasing product availability, and developing additional functional nutrition products. The Company operates a capital-light business model, utilizing third-party manufacturing, packaging, and fulfillment providers.
Results of Operation
For the Three Months ended June 30, 2026 and 2025
Revenue
Revenue for the three months ended June 30, 2026 was $540,359, compared to $341 for the three months ended June 30, 2025. The increase was primarily attributable to sales generated through the Company’s PRC subsidiary, reflecting continued distributor channel activity following the Company’s initial market entry in late 2025.
Revenue from the United States, including sales through the Amazon marketplace platform, was nominal during the current quarter and did not represent a significant portion of total revenue.
The prior-year quarter reflected minimal operating activity, as the Company had not yet commenced meaningful revenue-generating operations in its Asia-Pacific segment.
| 18 |
| Table of Contents |
Cost of Revenues and Gross Profit
Cost of revenues for the three months ended June 30, 2026 was $497,542, compared to $1,743 for the three months ended June 30, 2025. The increase was primarily attributable to higher sales volume in the current quarter, driven by distributor channel activity in China, along with associated product costs, packaging, logistics, and fulfillment expenses.
The Company operates a capital-light production model utilizing third-party manufacturers, co-packers, and specialized ingredient suppliers. The Company sources its diacylglycerol (“DAG”) oil from a strategic manufacturing partner in China. Due to the specialized nature of DAG oil production, supplier qualification requires technical capabilities and validation procedures.
Gross profit for the three months ended June 30, 2026 was $42,817, compared to a gross loss of $1,402 in the prior-year quarter. Gross margin remained modest in the current quarter, reflecting product mix, distributor pricing associated with early-stage channel development, logistics and fulfillment costs, and the impact of operating at relatively low scale, which limits fixed cost absorption.
Selling, General and Administrative Expenses
Selling, general and administrative expenses were $135,712 for the three months ended June 30, 2026, compared with $19,484 for the three months ended June 30, 2025. The increase was primarily attributable to higher executive compensation; investment banking, financial advisory, legal, accounting, and compliance expenses; and travel and business development activities associated with Project Verdant™, reflecting the expansion of the Company’s commercial operations and strategic development activities.
Net Loss
Net loss for the three months ended June 30, 2026 was $92,885, compared to a net loss of $20,885 for the three months ended June 30, 2025. While the Company generated meaningful revenue and positive gross profit in the current quarter, operating expenses increased as the Company invested in corporate infrastructure, professional services, and market expansion initiatives.
The increase in net loss relative to the prior-year quarter was primarily driven by higher selling, general and administrative expenses associated with scaling the business, partially offset by improved gross profit resulting from increased sales volume. Management expects operating expenses to remain elevated in the near term as the Company continues to invest in growth, while seeking to improve gross margins and operating leverage over time.
For the Nine Months Ended June 30, 2026 and 2025
Revenue
Revenue for the nine months ended June 30, 2026 was $1,039,001, compared to $947 for the nine months ended June 30, 2025. The increase was primarily attributable to the Company’s expansion into the Asia-Pacific market in late 2025, including initial distributor sales in December 2025 and continued distributor channel activity during the three months ended June 30, 2026.
Revenue from the United States, including sales through the Amazon marketplace platform, remained nominal during the current period and did not represent a significant portion of total revenue. The prior-year period reflected minimal operating activity and limited revenue generation.
| 19 |
| Table of Contents |
Cost of Revenues and Gross Profit
Cost of revenues for the nine months ended June 30, 2026 was $976,490, compared to $6,461 for the nine months ended June 30, 2025. The increase was primarily attributable to higher sales volume associated with distributor channel activity in China, along with related product costs, packaging, logistics, and fulfillment expenses.
The Company operates a capital-light production model utilizing third-party manufacturers, co-packers, and specialized ingredient suppliers. The Company sources its diacylglycerol (“DAG”) oil from a strategic manufacturing partner in China, and supplier qualification requires technical capabilities and validation procedures.
Gross profit for the nine months ended June 30, 2026 was $62,511, compared to a gross loss of $5,514 for the nine months ended June 30, 2025. Gross margin remained modest due to product mix, distributor pricing associated with early-stage market development, logistics and fulfillment costs, and the impact of operating at relatively low scale.
Selling, General and Administrative Expenses
Selling, general and administrative expenses were $399,639 for the nine months ended June 30, 2026, compared to $51,072 for the nine months ended June 30, 2025. The increase reflected the expansion of the Company’s commercial operations and strategic development activities.
For the nine months ended June 30, 2026, the Company engaged external advisors for corporate and strategic initiatives and incurred professional service fees, including investment banking, financial advisory, legal, accounting, consulting, and regulatory compliance expenses. The Company also incurred increased personnel-related expenses and travel and business development costs associated with Project Verdant™. The prior-year period reflected limited operations and correspondingly lower overhead expenses.
Net Loss
Net loss for the nine months ended June 30, 2026 was $337,062, compared to a net loss of $56,553 for the nine months ended June 30, 2025. While the Company generated meaningful revenue and positive gross profit during the current period, operating expenses increased as the Company invested in corporate infrastructure, professional services, and market expansion initiatives.
The increase in net loss relative to the prior-year period was primarily driven by higher selling, general and administrative expenses associated with scaling the business, partially offset by improved gross profit resulting from increased sales volume.
Liquidity and Capital Resources
As of June 30, 2026, the Company had a working capital deficiency of approximately $306,312 and has incurred recurring operating losses. The Company’s operations during the nine months ended June 30, 2026 were funded primarily through proceeds from the issuance of common stock to a non-affiliated investor. The Company has historically relied on related party funding to support operations.
Net cash used in operating activities was $219,109 for the nine months ended June 30, 2026 primarily reflected the net loss for the period, increases in inventory associated with initial distributor stocking and channel expansion, and payment of professional and advisory fees. These uses of cash were partially offset by increases in accounts payable, reflecting the timing of inventory purchases and vendor payments.
Net cash provided by financing activities was $150,000 for the nine months ended June 30, 2026 and consisted entirely of proceeds from the issuance of common stock to a non-affiliated investor. The conversion of $203,646 of related-party advances into common stock was a non-cash financing activity and therefore was excluded from net cash provided by financing activities.
| 20 |
| Table of Contents |
For the nine months ended June 30, 2025, net cash used in operating activities was 121,494 primarily reflected operating expenses and working capital changes, as the Company had minimal revenue and lower inventory purchases during that period. The increase in net cash used in operating activities during the nine months ended June 30, 2026 compared with the corresponding 2025 period was primarily attributable to increased inventory purchases, growth in accounts receivable, and higher operating expenses associated with expanded commercial activity.
For the nine months ended June 30, 2025, there was no net cash provided by or used in financing activities.
Inventory levels increased significantly during the period to support anticipated distributor demand and marketplace availability. Inventory levels are expected to fluctuate based on distributor demand, purchase timing, and logistics planning. If actual demand does not materialize as expected, the Company may be required to record inventory write-downs to net realizable value.
The Company expects that it will need additional capital to support operations, working capital requirements, and business development activities. Management is evaluating financing alternatives, which may include related-party funding, private placements, and other capital raising transactions. There can be no assurance that additional financing will be available on acceptable terms, or at all.
These conditions raise substantial doubt about the Company’s ability to continue as a going concern, as discussed in the Going Concern note to the condensed consolidated financial statements.
Critical Accounting Policies and Estimates
The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. Management has evaluated the accounting estimates used in preparing these financial statements and has determined that none involved a significant level of estimation uncertainty that had, or was reasonably likely to have, a material impact on the Company’s financial condition or results of operations for the periods presented. The Company’s significant accounting policies are described in Note 2 to the unaudited condensed consolidated financial statements included in this Quarterly Report.
Off-Balance Sheet Arrangements
As of June 30, 2026, the Company did not have any off-balance sheet arrangements, as defined in Item 303 of Regulation S-K, that have or are reasonably likely to have a current or future material effect on the Company’s consolidated financial condition, results of operations, liquidity, capital expenditures, or capital resources.
Recently Issued Accounting Standards
Recently issued accounting standards are described in Note 2 to the condensed consolidated financial statements. Management does not expect the adoption of standards not yet effective to have a material impact on the Company’s condensed consolidated financial statements.
ITEM 3. QUALITATIVE AND QUANTITATIVE DISCLOSURES ABOUT MARKET RISK
The Company is exposed to limited market risk in the ordinary course of its business, primarily related to foreign currency exchange risk and credit risk.
Foreign Currency Exchange Risk
The Company’s reporting currency is the U.S. dollar. Substantially all revenues and a majority of expenses during the nine months ended June 30, 2026 were denominated in U.S. dollars. During the period, the Company recorded limited sales and incurred certain expenses through its subsidiaries denominated in Renminbi, Hong Kong dollars, and Malaysian Ringgit.
The Company does not currently use derivative financial instruments or hedging arrangements to manage foreign currency risk. Based on the current level of foreign currency denominated transactions, management does not believe that a hypothetical 10% change in foreign currency exchange rates would have a material impact on the Company’s financial position, results of operations, or cash flows.
| 21 |
| Table of Contents |
Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and accounts receivable. The Company maintains cash balances with financial institutions it believes to be creditworthy. Accounts receivable arise primarily from marketplace platform settlements and distributor sales. The Company performs ongoing credit evaluations and maintains allowances for expected credit losses when appropriate.
Interest Rate Risk
The Company does not currently have material exposure to interest rate risk, as it does not maintain significant interest-bearing debt or interest-sensitive financial instruments.
ITEM 4. CONTROLS AND PROCEDURES
DISCLOSURE CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and Chief Financial Officer, the Company evaluated the effectiveness of its disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of June 30, 2026. Based on this evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were not effective as of that date due to deficiencies in internal control over financial reporting related to limited accounting personnel and segregation of duties.
Remediation
Management has begun implementing remediation measures to address these control deficiencies, including adding accounting and financial reporting resources, enhancing supervisory review controls, and improving segregation of duties where practical. The Company is also strengthening documentation and period-end review procedures. These remediation efforts are ongoing and will continue to be evaluated and refined.
Changes in Internal Control over Financial Reporting
Other than the remediation activities described above, there were no changes in the Company’s internal control over financial reporting during the quarter ended June 30, 2026 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
| 22 |
| Table of Contents |
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
The Company is not a party to any material legal proceedings. From time to time, the Company may be involved in ordinary course claims and matters that arise in the normal course of business. Management does not believe that the resolution of any such matters, if any, would have a material adverse effect on the Company’s financial condition, results of operations, or cash flows.
ITEM 1A. RISK FACTORS
The Company depends on a specialized DAG oil supplier in China. DAG oil production requires technical capabilities and supplier qualification procedures, which limits available sources. A disruption in supply could delay production, increase costs, or reduce product availability.
A single supplier accounted for a substantial majority of the Company’s cost of sales for the quarter ended June 30, 2026. This supplier concentration increases exposure to supply interruption and pricing risk, which could adversely affect margins and operations.
A substantial portion of the Company’s quarterly revenue was derived from two distributors in China. The Company may not receive future orders from this distributor at similar volumes or pricing levels, and the loss of this distributor or a reduction in its purchases could materially adversely affect the Company’s revenues, cash flows, and results of operations.
The Company relies on third-party manufacturers, co-packers, and logistics providers. Service interruptions, capacity limits, or cost increases at these providers could disrupt fulfillment and increase operating costs.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
On January 19, 2026, the Company issued an aggregate of 814,588 shares of its common stock to its Chief Executive Officer and a director in connection with the conversion of $203,647 of advances at a conversion price of $0.25 per share. The issuance was conducted in a private transaction and was exempt from registration under the Securities Act of 1933, as amended, pursuant to Section 4(a)(2).
On February 26, 2026, the Company issued 500,000 shares of its common stock to a non-affiliated investor at a purchase price of $0.30 per share, for total gross proceeds of $150,000. The issuance was conducted in a private placement and was exempt from registration under the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) and/or Regulation D thereunder.
The Company intends to use the proceeds from the sale of shares for general working capital and corporate purposes.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
None
| 23 |
| Table of Contents |
ITEM 6. EXHIBITS
The following exhibits are filed as part of this Quarterly Report.
Exhibit No. |
| Description |
| Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer | |
| Rule 13(a)-14(a)/15(d)-14(a) Certification of principal financial officer | |
| ||
| ||
101 |
| Interactive data files pursuant to Rule 405 of Regulation S-T. |
101.INS |
| Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document). |
101.SCH |
| Inline XBRL Taxonomy Extension Schema Document. |
101.CAL |
| Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
101.DEF |
| Inline XBRL Taxonomy Extension Definition Linkbase Document. |
101.LAB |
| Inline XBRL Taxonomy Extension Labels Linkbase Document. |
101.PRE |
| Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
104 |
| Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). |
| 24 |
| Table of Contents |
SIGNATURES
Pursuant to the requirements of Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
| UMEWORLD INC. |
|
|
|
|
|
Dated: August 13, 2026 |
| /s/ Michael Lee |
|
|
| Michael Lee |
|
|
| CEO, President, and Director |
|
|
| (Principal Executive Officer) |
|
Dated: August 13, 2026 |
| /s/ Winfield Ding |
|
|
| Winfield Ding |
|
|
| Chief Financial Officer |
|
|
| (Principal Financial and Accounting Officer |
|
| 25 |
EXHIBIT 31.1
Certification by the Principal Executive Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Michael Lee, certify that:
| 1. | I have reviewed this quarterly report on Form 10-Q of UMeWorld Inc.; |
|
|
|
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
|
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report; |
|
|
|
| 4. | The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have: |
|
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
|
|
|
| (b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
|
|
|
| (c) | Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
|
|
| (d) | Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the quarterly report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and |
|
|
|
|
| 5. | The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions): | |
|
|
|
|
|
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and |
|
|
|
|
|
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting. |
| Date: August 13, 2026 | By: | /s/ Michael Lee |
|
|
| Name: | Michael Lee |
|
|
| Title: | President and Chief Executive Officer |
|
EXHIBIT 31.2
Certification by the Principal Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Winfield Ding, certify that:
| 1. | I have reviewed this quarterly report on Form 10-Q of UMeWorld Inc.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report; |
| 4.
| The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have: |
|
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
| (b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
| (c) | Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
| (d) | Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the quarterly report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and |
| 5. | The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions): |
|
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and |
|
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting. |
| Date: August 13, 2026 | By: | /s/ Winfield Ding |
|
|
| Name: | Winfield Ding |
|
|
| Title: | Chief Financial Officer |
|
EXHIBIT 32.1
Certification by the Principal Executive Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report of UMeWorld Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2026 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Lee, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
|
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: August 13, 2026 | By: | /s/ Michael Lee |
|
|
| Name: | Michael Lee |
|
|
| Title: | President and Chief Executive Officer |
|
EXHIBIT 32.2
Certification by the Principal Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report of UMeWorld Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2026 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Winfield Ding, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
|
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: August 13, 2026 | By: | /s/ Winfield Ding |
|
|
| Name: | Winfield Ding |
|
|
| Title: | Chief Financial Officer |
|